Protocol: Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation (30 May, 2022)
Kosuke Tanaka , Takaomi Kessoku , Atsushi Yamamoto , Kota Takahashi , Yuki Kasai , Anna Ozaki , Michihiro Iwaki , Takashi Kobayashi , Tsutomu Yoshihara , Noboru Misawa , Takayuki Kato , Jun Arimoto , Akiko Fuyuki , Eiji Sakai , Takuma Higurashi , Hideyuki Chiba , Kunihiro Hosono , Masato Yoneda , Tomoyuki Iwasaki , Takeo Kurihashi , Machiko Nakatogawa , Ayao Suzuki , Masataka Taguri , Shunsuke Oyamada , Keisuke Ariyoshi , Noritoshi Kobayashi , Yasushi Ichikawa , Atsushi Nakajima